Pharmacokinetic profiles of a SARS-COV-2 neutralizing antibody BD-604 in cynomolgus monkeys,Drug Testing and Analysis

当前位置： X-MOL 学术 › Drug Test. Anal. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Pharmacokinetic profiles of a SARS-COV-2 neutralizing antibody BD-604 in cynomolgus monkeys
Drug Testing and Analysis ( IF 2.6 ) Pub Date : 2021-07-02 , DOI: 10.1002/dta.3122
Feng Gao ₁ , Xu Zhang ₁

Affiliation

Currently, severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) has spread worldwide as a severe pandemic and effective therapeutic medications are urgently needed. As reported previously, BD-604 is a fully human monoclonal antibody with strong in vitro and in vivo neutralizing activity to SARS-COV-2.

中文翻译：

SARS-COV-2中和抗体BD-604在食蟹猴体内的药代动力学特征

目前，严重急性呼吸综合征冠状病毒 2 (SARS-COV-2) 已在世界范围内传播，因为严重的大流行和迫切需要有效的治疗药物。如前所述，BD-604是一种全人源单克隆抗体，在体外和体内对SARS-COV-2具有很强的中和活性。

更新日期：2021-07-02

点击分享查看原文

点击收藏

阅读更多本刊最新论文本刊介绍/投稿指南11